Clearance Summary
PreemptiveAI Clinical SDK received FDA 510(k) clearance under submission number K250233, sponsored by Measure Labs, Inc. (Dba Preemptiveai, Inc.). The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2026-02-13.
- Submission: K250233
- Applicant / Sponsor: Measure Labs, Inc. (Dba Preemptiveai, Inc.)
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2920
- Decision date: 2026-02-13
Classification & Regulation
This clearance is catalogued under FDA product code DXH and 21 CFR 870.2920, within the Cardiovascular review panel as a Class II device.